0001209191-15-052410.txt : 20150611 0001209191-15-052410.hdr.sgml : 20150611 20150611181713 ACCESSION NUMBER: 0001209191-15-052410 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150610 FILED AS OF DATE: 20150611 DATE AS OF CHANGE: 20150611 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD STREET 2: SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Herman Melanie J CENTRAL INDEX KEY: 0001605325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 15927022 MAIL ADDRESS: STREET 1: 11119 NORTH TORREY PINES ROAD, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-06-10 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001605325 Herman Melanie J 11119 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 0 1 0 0 Interim CFO Common Stock 2015-06-10 4 M 0 1500 11.91 A 4486 D Common Stock 2015-06-10 4 M 0 875 21.92 A 5361 D Common Stock 2015-06-10 4 M 0 1750 68.48 A 7111 D Common Stock 2015-06-10 4 S 0 4125 93.50 D 2986 D Employee Stock Option (right to buy) 11.91 2015-06-10 2015-06-10 4 M 0 1500 0.00 D 2022-01-03 Common Stock 1500 875 D Employee Stock Option (right to buy) 21.92 2015-06-10 2015-06-10 4 M 0 875 0.00 D 2023-02-15 Common Stock 875 1312 D Employee Stock Option (right to buy) 68.48 2015-06-10 2015-06-10 4 M 0 1750 0.00 D 2024-04-01 Common Stock 1750 4250 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.50 to $93.515, inclusive. The reporting person undertakes to provide, upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Grant to reporting person of options, exercisable six months after the date of grant. The date of grant is 01/03/2012. Grant to reporting person of options, exercisable six months after the date of grant. The date of grant is 02/15/2013. Grant to reporting person of options, exercisable six months after the date of grant. The date of grant is 04/01/2014. /s/ Charles S. Berkman, For: Melanie J. Herman 2015-06-11